228 related articles for article (PubMed ID: 30544105)
21. Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs.
Laidlaw TM; Cahill KN
J Allergy Clin Immunol Pract; 2017; 5(3):537-545. PubMed ID: 28483309
[TBL] [Abstract][Full Text] [Related]
22. Immediate Reactions to More Than 1 NSAID Must Not Be Considered Cross-Hypersensitivity Unless Tolerance to ASA Is Verified.
Pérez-Alzate D; Cornejo-García JA; Pérez-Sánchez N; Andreu I; García-Moral A; Agúndez JA; Bartra J; Doña I; Torres MJ; Blanca M; Blanca-López N; Canto G
J Investig Allergol Clin Immunol; 2017; 27(1):32-39. PubMed ID: 28211343
[TBL] [Abstract][Full Text] [Related]
23. Aspirin desensitization in aspirin-exacerbated respiratory disease.
White AA; Stevenson DD
Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
[TBL] [Abstract][Full Text] [Related]
24. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease.
McMullan KL; Wedner HJ
Clin Cardiol; 2013 Jan; 36(1):25-30. PubMed ID: 22990948
[TBL] [Abstract][Full Text] [Related]
25. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
[TBL] [Abstract][Full Text] [Related]
26. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
Cohn JR
Ann Allergy Asthma Immunol; 2007 Aug; 99(2):196; author reply 196-7. PubMed ID: 17718110
[No Abstract] [Full Text] [Related]
27. Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.
Mahdavinia M; Batra PS; Codispoti C
Ann Allergy Asthma Immunol; 2019 Sep; 123(3):311-312. PubMed ID: 31247304
[No Abstract] [Full Text] [Related]
28. Mesalamine desensitization in a patient with treatment refractory ulcerative colitis and aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.
Heath JL; Heath RD; Tamboli C; Johnson L; Wilson AS; Chervinskiy S; Bell MC; Kennedy JL
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):518-520. PubMed ID: 28284977
[No Abstract] [Full Text] [Related]
29. Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity.
Yilmaz Topal O; Kulhas Celik I; Turgay Yagmur I; Toyran M; Civelek E; Karaatmaca B; Kocabas CN; Dibek Misirlioglu E
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):202-207. PubMed ID: 32294526
[TBL] [Abstract][Full Text] [Related]
30. [Self-desensitization with aspirin in a patient with aspirin intolerance].
Rozsasi A; Keck T
Laryngorhinootologie; 2009 Aug; 88(8):540-1. PubMed ID: 19562656
[No Abstract] [Full Text] [Related]
31. Clinical Trials of Aspirin Treatment After Desensitization in Aspirin-Exacerbated Respiratory Disease.
Kowalski ML; Wardzyńska A; Makowska JS
Immunol Allergy Clin North Am; 2016 Nov; 36(4):705-717. PubMed ID: 27712765
[TBL] [Abstract][Full Text] [Related]
32. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.
Doña I; Blanca-López N; Jagemann LR; Torres MJ; Rondón C; Campo P; Gómez AI; Fernández J; Laguna JJ; Rosado A; Blanca M; Canto G
Allergy; 2011 Nov; 66(11):1428-33. PubMed ID: 21834936
[TBL] [Abstract][Full Text] [Related]
33. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
Waldram J; Walters K; Simon R; Woessner K; Waalen J; White A
J Allergy Clin Immunol; 2018 Jan; 141(1):250-256. PubMed ID: 28550988
[TBL] [Abstract][Full Text] [Related]
34. Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease).
Rossini R; Iorio A; Pozzi R; Bianco M; Musumeci G; Leonardi S; Lettieri C; Bossi I; Colombo P; Rigattieri S; Dossena C; Anzuini A; Capodanno D; Senni M; Angiolillo DJ
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193678
[TBL] [Abstract][Full Text] [Related]
35. The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease.
White AA; Bosso JV; Stevenson DD
Allergy Asthma Proc; 2013; 34(4):378-382. PubMed ID: 23883603
[TBL] [Abstract][Full Text] [Related]
36. Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.
Kong JS; Teuber SS; Gershwin ME
Clin Rev Allergy Immunol; 2007 Feb; 32(1):97-110. PubMed ID: 17426365
[TBL] [Abstract][Full Text] [Related]
37. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
[TBL] [Abstract][Full Text] [Related]
38. Selection of patients for aspirin desensitization treatment.
Stevenson DD; Simon RA
J Allergy Clin Immunol; 2006 Oct; 118(4):801-4. PubMed ID: 17030229
[No Abstract] [Full Text] [Related]
39. Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.
Doña I; Barrionuevo E; Salas M; Cornejo-García JA; Perkins JR; Bogas G; Prieto A; Torres MJ
Allergy; 2017 Sep; 72(9):1346-1355. PubMed ID: 28226401
[TBL] [Abstract][Full Text] [Related]
40. Hypersensitivity to aspirin and urgent percutaneous coronary intervention: A therapeutic challenge.
Duarte T; Gonçalves S; Sá C; Marinheiro R; Rodrigues R; Seixo F; Tomas E; Caria R
Rev Port Cardiol; 2016 Nov; 35(11):619.e1-619.e5. PubMed ID: 27717518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
